申请人:Epizyme, Inc.
公开号:US20160068559A1
公开(公告)日:2016-03-10
Disclosed are compounds, pharmaceutical compositions containing the compounds, and the uses of the compounds and compositions as modulators of histone methyltransferases, and for treating diseases influenced by modulation of histone methyltransferase activity.
本发明涉及一种化合物、含有该化合物的药物组合物,以及将该化合物和组合物用作组蛋白甲基转移酶调节剂,以及治疗受组蛋白甲基转移酶活性调节影响的疾病的用途。